삼성서울병원

Ko En
의료진 검색
찾으실 의료진명을 입력하여 검색해주세요.

영상의학과 김영곤 교수

진료분야
복부영상의학
진료일정 04 月
날짜
월
01
화
02
수
03
목
04
금
05
토
06
일
07
월
08
화
09
수
10
목
11
금
12
토
13
일
14
월
15
화
16
수
17
목
18
금
19
토
20
일
21
월
22
화
23
수
24
목
25
금
26
토
27
일
28
월
29
화
30
오전
오후
진료일정 05 月
날짜
수
01
목
02
금
03
토
04
일
05
월
06
화
07
수
08
목
09
금
10
토
11
일
12
월
13
화
14
수
15
목
16
금
17
토
18
일
19
월
20
화
21
수
22
목
23
금
24
토
25
일
26
월
27
화
28
수
29
목
30
금
31
오전
오후
본원외래 본원클리닉 본원육아상담 암병원외래 암병원클리닉 암병원육아상담

학력

학력
1995.02 전북대학교 의학과 학사

경력

경력
2017.04 ~현재 성균관대학교 의과대학 삼성서울병원 영상의학과 교수
2011.03 ~현재 성균관대학교 의과대학 삼성서울병원 영상의학과 부교수
2010.08 ~ 2011.02 삼성서울병원 임상부교수
2005.01 ~ 2010.07 전북대학교 의과대학 조교수
2002.01 ~ 2004.12 전북대학교병원 전임의, 임상교수
2001.01 ~ 2001.12 제주한국병원 진료과장
1997.01 ~ 2000.12 전북대학교병원 수련의
논문
  • EUR J RADIOL 2023 10.1016/j.ejrad.2023.111183 The role of subspecialized radiologist reviews in preoperative conference for hepato-pancreato-biliary disease Seo, Y; Min, JH; Kim, SH; Kim, YK; Kim, H; Cha, DI; Lee, JH; Heo, JS; Han, IW; Shin, SH; Kim, H; Yoon, SJ; Choi, SY
    View PubMed
  • CLIN IMAG 2023 10.1016/j.clinimag.2023.05.018 Comparison of noncontrast, dynamic, and hepatobiliary phase abbreviated MRI protocols for detection of hepatic malignancies* Lee, JH; Kim, YK; Min, JH; Cha, D; Hwang, JA; Ahn, S
    View PubMed
  • CANCER MED-US 2023 10.1002/cam4.5530 Comprehensive immunoprofile analysis of prognostic markers in pancreaticobiliary tract cancers Kim, JE; Kim, H; Kim, B; Chung, HG; Chung, HH; Kim, KM; Kim, SH; Jeong, WK; Kim, YK; Min, JH; Heo, JS; Han, IW; Shin, SH; Park, HC; Yu, JI; Park, JO; Kim, ST; Hong, JY; Lee, SH; Lee, KH; Lee, JK; Lee, KT; Jang, KT; Park, JK
    View PubMed
  • AM J ROENTGENOL 2022 10.2214/AJR.22.27739 Utility of Diffusion-Weighted MRI for Detection of Locally Recurrent Pancreatic Cancer After Surgical Resection Shin, N; Kang, TW; Min, JH; Hwang, JA; Kim, YK; Kim, YY; Han, IW; Kim, K
    View PubMed
  • EUR J RADIOL 2022 10.1016/j.ejrad.2022.110328 Association between intensity of imaging surveillance and clinical outcomes in patients with hepatocellular carcinoma Hwang, JA; Kang, TW; Min, JH; Kim, YK; Kim, SH; Sinn, DH; Kim, K
    View PubMed
  • MED ULTRASON 2021 10.11152/mu-2906 Quantitative analysis of contrast-enhanced ultrasonography following living donor liver transplantation: early diagnosis of middle hepatic venous occlusion Im, J; Jeong, WK; Lee, MW; Kim, YK; Min, JH; Kim, JM; Choi, GS; Joh, JW
    View PubMed
  • KOREAN J RADIOL 2021 10.3348/kjr.2020.1428 Prognosis after Curative Resection of Single Hepatocellular Carcinoma with A Focus on LI-RADS Targetoid Appearance on Preoperative Gadoxetic Acid-Enhanced MRI Moon, JY; Min, JH; Kim, YK; Cha, D; Hwang, JA; Ko, SE; Choi, SY; Yun, EJ; Kim, SW; Won, HJ
    View PubMed
  • EUR RADIOL 2021 10.1007/s00330-021-08124-0 A modified LI-RADS: targetoid tumors with enhancing capsule can be diagnosed as HCC instead of LR-M lesions Min, JH; Kim, JM; Kim, YK; Kim, H; Choi, GS; Kang, TW; Cha, D; Hwang, JA; Ko, SE; Ahn, S
    View PubMed
  • LIVER INT 2021 10.1111/liv.15012 EASL versus LI-RADS: Intra-individual comparison of MRI with extracellular contrast and gadoxetic acid for diagnosis of small HCC Min, JH; Kim, JM; Kim, YK; Kim, H; Cha, DI; Kang, TW; Choi, GS; Choi, SY; Ahn, S
    View PubMed
  • EUR RADIOL 2021 10.1007/s00330-021-07897-8 Assessment of factors affecting washout appearance of hepatocellular carcinoma on CT Hwang1, JA; Min, JH; Kang, TW; Jeong, WK; Kim, YK; Ko, SE; Choi, SY
    View PubMed
  • EUR J RADIOL 2021 10.1016/j.ejrad.2020.109474 Gadoxetic acid-enhanced MRI for differentiating hepatic sclerosing hemangioma from malignant tumor Kim1, YY; Kang, TW; Cha, DI; Min, JH; Kim, YK; Kim, SH; Sinn, DH; Won, H; Kim, S
    View PubMed
  • EUR RADIOL 2021 10.1007/s00330-020-07583-1 Intraductal papillary mucinous neoplasm of the pancreas: diagnostic performance of the 2017 international consensus guidelines using CT and MRI Min1, JH; Kim, YK; Kim, SK; Kim, H; Ahn, S
    View PubMed
  • RADIOLOGY 2021 10.1148/radiol.2020200885 Comparison of Super-Resolution US and Contrast Material-enhanced US in Detection of the Spoke Wheel Sign in Patients with Focal Nodular Hyperplasia Kang1, TW; Jeong, WK; Kim, YY; Min, JH; Kim, YK; Kim, SH; Sinn, DH; Kim, K
    View PubMed
  • EUR RADIOL 2020 10.1007/s00330-020-07438-9 Vanishing washout of hepatocellular carcinoma according to the presence of hepatic steatosis diagnostic performance of CT and MRI Min1, JH; Kang, TW; Kim, YY; Cha, DI; Kim, YK; Kim, SH; Sinn, DH; Ha, SY; Kim, K
    View PubMed
  • CLIN GASTROENTEROL H 2020 10.1016/j.cgh.2019.12.010 Magnetic Resonance Imaging With Extracellular Contrast Detects Hepatocellular Carcinoma With Greater Accuracy Than With Gadoxetic Acid or Computed Tomography Min1, JH; Kim, JM; Kim, YK; Cha, DI; Kang, TW; Kim, H; Choi, GS; Choi, SY; Ahn, S
    View PubMed
  • CLIN RADIOL 2020 10.1016/j.crad.2020.01.002 Targetoid hepatic observations on gadoxetic acid-enhanced MRI using LI-RADS version 2018: emphasis on hepatocellular carcinomas assigned to the LR-M category Park1, HJ; Kim, YK; Cha, DI; Ko, SE; Kim, S; Lee, ES; Ahn, S
    View PubMed
  • RADIOLOGY 2020 10.1148/radiol.2020190639 Use of Gadoxetic Acid enhanced Liver MRI and Morality in More than 30000 Patients with Hepatocellular Carcinoma: A Nationwide Analysis Kang1, TW; Kong, SY; Kang, D; Kang, MW; Kim, YK; Kim, SH; Sinn, DH; Kim, YA; Choi, KS; Lee, ES; Cho, J; Guallar, E; Back, JH; Woo, SM
    View PubMed
  • KOREAN J RADIOL 2020 10.3348/kjr.2019.0538 Preoperative Prediction for Early Recurrence Can Be as Accurate as Postoperative Assessment in Single Hepatocellular Carcinoma Patients Cha1, DI; Jang, KM; Kim, SH; Kim, YK; Kim, H; Ahn, SH
    View PubMed
  • CLIN RADIOL 2020 10.1016/j.crad.2019.11.004 Comparison of the diagnostic performance of the 2017 and 2018 versions of LI-RADS for hepatocellular carcinoma on gadoxetic acid enhanced MRI Ko1, A; Park, HJ; Lee, ES; Park, SB; Kim, YK; Choi, SY; Ahn, S
    View PubMed
  • EUR RADIOL 2020 10.1007/s00330-020-06753-5 Extracellular contrast-enhanced MRI with diffusion-weighted imaging for HCC diagnosis: prospective comparison with gadoxetic acid using LI-RADS Cha1, DI; Choi, GS; Kim, YK; Kim, JM; Kang, TW; Song, KD; Ahn, SH
    View PubMed
  • Abdom Radiol (NY) 2019 10.1007/s00261-019-02068-2 Differentiation of hypervascular primary hepatic tumors showing hepatobiliary hypointensity on gadoxetic acid-enhanced magnetic resonance imaging Park1, HJ; Kim, YK; Min, JH; Lee, J; Lee, SJ; Lee, ES; Ahn, S
    View PubMed
  • Abdom Radiol (NY) 2019 10.1007/s00261-019-01968-7 Diagnosis of recurrent HCC: intraindividual comparison of gadoxetic acid MRI and extracellular contrast-enhanced MRI Yim1, JH; Kim, YK; Min, JH; Lee, J; Kang, TW; Lee, SJ
    View PubMed
  • ACTA RADIOL 2019 10.1177/0284185118805253 Evaluation of early treatment response to radiotherapy for HCC using pre- and post-treatment MRI Song1, SH; Jeong, WK; Choi, D; Kim, YK; Park, HC; Yu, JI
    View PubMed
  • CLIN IMAG 2019 10.1016/j.clinimag.2019.02.013 Usefulness of non-contrast MR imaging in distinguishing pancreatic ductal adenocarcinoma from focal pancreatitis Lee1, JH; Min, JH; Kim, YK; Cha, DI; Lee, J; Park, HJ; Ahn, S
    View PubMed
  • MEDICINE 2019 10.1097/MD.0000000000015867 Semiautomatic software for measurement of abdominal muscle and adipose areas using computed tomography A STROBE-compliant article Kim1, SS; Kim, JH; Jeong, WK; Lee, J; Kim, YK; Choi, D; Lee, WJ
    View PubMed
  • Abdom Radiol (NY) 2019 10.1007/s00261-018-1847-y Differentiation between inflammatory myofibroblastic tumor and cholangiocarcinoma manifesting as target appearance on gadoxetic acid-enhanced MRI Chang1, AI; Kim, YK; Min, JH; Lee, J; Kim, H; Lee, SJ
    View PubMed
  • EUR RADIOL 2019 10.1007/s00330-018-5771-x Intra-individual comparison of gadolinium-enhanced MRI using pseudo-golden-angle radial acquisition with gadoxetic acid-enhanced MRI for diagnosis of HCCs using LI-RADS Kim1, YC; Min, JH; Kim, YK; Lee, SJ; Ahn, S; Kim, E; Peeters, H
    View PubMed
  • ACTA RADIOL 2019 10.1177/0284185118788901 Non-contrast liver MRI as an alternative to gadoxetic acid-enhanced MRI for liver metastasis from colorectal cancer Hwang1, JA; Kim, YK; Min, JH; Song, KD; Sohn, I; Ahn, HS
    View PubMed
  • RADIOLOGY 2019 10.1118/radiol.2018181485 Intrahepatic Mass-formimg Cholangiocarcinoma: Arterial Enhancement Patterns at MRI and Prognosis Min1, JH; Kim, YK; Choi, SY; Kang, TW; Lee, SJ; Kim, JM; Ahn, S; Cho, H
    View PubMed
  • CLIN IMAG 2019 10.1016/j.clinimag.2018.12.001 Usefulness of noncontrast MRI in differentiation between gallbladder carcinoma and benign conditions manifesting as focal mild wall thickening Cha1, SY; Kim, YK; Min, JH; Lee, J; Cha, DI; Lee, SJ
    View PubMed
  • KOREAN J RADIOL 2019 10.3348/kjr.2018.0339 Identification of Arterial Hyperenhancement in CT and MRI in Patients with Hepatocellular Carcinoma: Value of Unenhanced Images Kim1, M; Kang, TW; Cha, DI; Jang, KM; Kim, YK; Kim, SH; Sinn, DH; Kim, K
    View PubMed
  • HEPATOLOGY 2018 10.1002/hep.30122 Prospective Intraindividual Comparison of Magnetic Resonance Imaging With Gadoxetic Acid and Extracellular Contrast for Diagnosis of Hepatocellular Carcinomas Using the Liver Imaging Reporting and Data System Min1, JH; Kim, JM; Kim, YK; Kang, TW; Lee, SJ; Choi, GS; Choi, SY; Ahn, S
    View PubMed
  • Abdom Radiol (NY) 2018 10.1007/s00261-018-1653-6 Hepatic neuroendocrine tumors: gadoxetic acid-enhanced magnetic resonance imaging findings with an emphasis on differentiation between primary and secondary tumors Cha1, DI; Kang, TW; Jang, KM; Kim, YK; Kim, SH; Ha, SY; Sohn, I
    View PubMed
  • BRIT J RADIOL 2018 10.1259/bjr.20180177 Detection of recurrent hepatocellular carcinoma after surgical resection: Non-contrast liver MR imaging with diffusion-weighted imaging versus gadoxetic acid-enhanced MR imaging Min1, JH; Kim, YK; Choi, SY; Kang, TW; Jeong, WK; Kim, K; Won, HJ
    View PubMed
  • Abdom Radiol (NY) 2018 10.1007/s00261-018-1480-9 Adding ancillary features to enhancement patterns of hepatocellular carcinoma on gadoxetic acid-enhanced magnetic resonance imaging improves diagnostic performance Min1, JH; Kim, YK; Sinn, DH; Choi, SY; Jeong, WK; Lee, WJ; Ha, SY; Ahn, S; Kim, MJ
    View PubMed
  • EUR RADIOL 2018 10.1007/s00330-018-5307-4 Artifacts during the arterial phase of gadoxetate disodium-enhanced MRI: Multiple arterial phases using view-sharing from two different vendors versus single arterial phase imaging Min1, JH; Kim, YK; Kang, TW; Jeong, WK; Lee, WJ; Ahn, S; Hwang, NY
    View PubMed
  • ACTA RADIOL 2018 10.1177/0284185117728534 Intra-individual comparison of hepatocellular carcinoma imaging computed tomconstrast-enhancedtte computed tomography, gadopentetate dimeglumine-enhanced MRI, and gadoxetic acid-enhanced MRI Kim1, YN; Song, JS; Moon, WS; Hwang, HP; Kim, YK
    View PubMed
  • J HEPATOL 2018 10.1016/j.jhep.2018.01.024 Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma Kim1, AY; Sinn, DH; Jeong, WK; Kim, YK; Kang, TW; Ha, SY; Park, CK; Choi, GS; Kim, JM; Kwon, CHD; Joh, JW; Kim, MJ; Sohn, I; Jung, SH; Paik, SW; Lee, WJ
    View PubMed
  • CLIN RADIOL 2018 10.1016/j.crad.2018.01.016 Prediction and clinical implications of portal vein/superior mesenteric vein invasion in patients with resected pancreatic head cancer: the significance of preoperative CT parameters Kim1, M; Kang, TW; Cha, DI; Kim, YK; Kim, SH; Jang, KT; Han, IW; Sohn, I
    View PubMed
  • EUR RADIOL 2018 10.1007/s00330-017-5196-y Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging Choi1, SY; Kim, YK; Min, JH; Kang, TW; Jeong, WK; Ahn, S; Won, H
    View PubMed
  • EUR RADIOL 2018 10.1007/s00330-017-5248-3 Hepatic neuroendocrine tumour: Apparent diffusion coefficient as a potential marker of prognosis associated with tumour grade and overall survival Min1, JH; Kang, TW; Kim, YK; Kim, SH; Shin, KS; Lee, JE; Ha, SY; Sohn, I
    View PubMed
  • ACTA RADIOL 2018 10.1177/0284185117723040 Hepatocellular carcinoma with central scar on gadoxetic acid-enhanced and diffusion-weighted magnetic resonance imaging Han1, SB; Kim, YK; Min, JH; Ha, SY; Jeong, WK; Lee, WJ
    View PubMed
  • EUR RADIOL 2018 10.1007/s00330-017-4926-5 Comparison between MRI with MR cholangiopancreatography and endoscopic ultrasonography for differentiating malignant from benign mucinous neoplasms of the pancreas Hwang1, J; Kim, YK; Min, JH; Jeong, WK; Hong, SS; Kim, HJ
    View PubMed
  • CLIN IMAG 2018 10.1016/j.clinimag.2017.08.004 The qualitative and quantitative image analysis of MR imaging in patients with acute-on-chronic liver failure Kang1, TW; Kim, M; Kim, YK; Kim, SH; Sinn, DH; Kim, K
    View PubMed
  • CLIN RADIOL 2017 10.1016/j.crad.2017.07.009 Value of unenhanced MRI with diffusion-weighted imaging for detection of primary small (<= 20 mm) solid pancreatic tumours and prediction of pancreatic ductal adenocarcinoma Park1, HJ; Jang, KM; Song, KD; Kim, SH; Kim, YK; Cha, MJ; Choi, SY; Min, K
    View PubMed
  • EUR RADIOL 2017 10.1007/s00330-017-4846-4 Capsule, septum, and T2 hyperintense foci for differentiation between large hepatocellular carcinoma (>= 5 cm) and intrahepatic cholangiocarcinoma on gadoxetic acid MRI Hwang1, J; Kim, YK; Min, JH; Choi, SY; Jeong, WK; Hong, SS; Kim, HJ; Ahn, S; Ahn, HS
    View PubMed
  • ACTA RADIOL 2017 10.1177/0284185116685921 Diagnostic accuracy of diffusion restriction in intraductal papillary mucinous neoplasm of the pancreas in comparison with "high-risk stigmata'' of the 2012 international consensus guidelines for prediction of the malignancy and invasiveness Kim1, M; Jang, KM; Kim, SH; Song, KD; Jeong, WK; Kang, TW; Kim, YK; Cha, DI; Kim, K; Yoo, H
    View PubMed
  • EUR J RADIOL 2017 10.1016/j.ejard.2017.036 Association between non-hypervascular hypointense nodules on gadoxetic acid-enhanced MRI and liver stiffness or hepatocellular carcinoma Hwang1, JA; Kang, TW; Kim, YK; Kim, SH; Paik, YH; Ha, SY; Kim, S
    View PubMed
  • EUR RADIOL 2017 10.1007/s00330-017-4782-3 The value of gadoxetic acid-enhanced MRI for differentiation between hepatic microabscesses and metastases in patients with periampullary cancer Choi1, SY; Kim, YK; Min, JH; Cha, DI; Jeong, WK; Lee, WJ
    View PubMed
  • Abdom Radiol (NY) 2017 10.1007/s00261-017-1119-2 Magnetic resonance findings of hepatic epithelioid hemangioendothelioma: emphasis on hepatobiliary phase using Gd-EOB-DTPA Lee1, JH; Jeong, WK; Kim, YK; Lee, WJ; Ha, SY; Kim, KW; Kim, J
    View PubMed
  • Clin Neuroradiol 2017 10.1007/s00062-016-0508-1 Differentiation of Hemangioblastoma from Metastatic Brain Tumor using Dynamic Contrast-enhanced MR Imaging Cha1, J; Kim, ST; Nam, DH; Kong, DS; Kim, HJ; Kim, YK; Kim, HY; Park, GM; Jeon, P; Kim, KH; Byun, HS
    View PubMed
  • EUR RADIOL 2017 10.1007/s00330-016-4662-2 Gadoxetic acid-enhanced magnetic resonance imaging characteristics of hepatocellular carcinoma occurring in liver transplants Kim1, M; Kang, TW; Jeong, WK; Kim, YK; Kim, SH; Kim, JM; Sinn, DH; Kim, MJ; Jung, SH
    View PubMed
  • EUR RADIOL 2017 10.1007/s00330-016-4644-4 Disappearing or residual tiny (ae<currency>5 mm) colorectal liver metastases after chemotherapy on gadoxetic acid-enhanced liver MRI and diffusion-weighted imaging: Is local treatment required? Kim1, SS; Song, KD; Kim, YK; Kim, HC; Huh, JW; Park, YS; Park, JO; Kim, ST
    View PubMed
  • EUR J RADIOL 2017 10.1016/j.ejrad.2017.04.008 Differentiation between cholangiocarcinoma and hepatocellular carcinoma with target sign on diffusion-weighted imaging and hepatobiliary phase gadoxetic acid-enhanced MR imaging: Classification tree analysis applying capsule and septum Min1, JH; Kim, YK; Choi, SY; Jeong, WK; Lee, WJ; Ha, SY; Ahn, S; Ahn, HS
    View PubMed
  • Korean J Radiol. 2017 May-Jun;18(3):427-443. doi: 10.3348/kjr.2017.18.3.427. Epub 2017 Apr 3. Diagnosis of Hepatocellular Carcinoma with Gadoxetic Acid-Enhanced MRI: 2016 Consensus Recommendations of the Korean Society of Abdominal. Radiology 1,Korean Society of Abdominal Radiology.
    View PubMed
  • Abdom Radiol (NY). 2017 May;42(5):1424-1433. doi: 10.1007/s00261-016-1038-7. Imaging features of hepatic sarcomatous carcinoma on computed tomography and gadoxetic acid-enhanced magnetic resonance imaging Gu KW11, Kim YK2, Min JH1, Ha SY3, Jeong WK1.
    View PubMed
  • Eur Radiol. 2017 Apr;27(4):1722-1732. doi: 10.1007/s00330-016-4522-0. Epub 2016 Aug 10. Differentiation of mass-forming focal pancreatitis from pancreatic ductal adenocarcinoma: value of characterizing dynamic enhancement patterns on contrast-enhanced MR images by adding signal intensity color mapping Kim M11, Jang KM2,3, Kim JH4, Jeong WK4, Kim SH4, Kang TW4, Kim YK4, Cha DI4, Kim K5.
    View PubMed
  • Acta Radiol. 2016 Dec;57(12):1429-1437. doi: 10.1177/0284185115626472. Epub 2016 Jul 19. Iterative reconstruction: comparison of techniques for reduced-dose liver computed tomography following transarterial chemoembolization for hepatocellular carcinoma Cha MJ11, Jeong WK1, Choi D1, Kim YK1, Lim S1,2, Choi SY1,3, Lee WJ1.
    View PubMed
  • Eur Radiol. 2016 Sep;26(9):3102-11. doi: 10.1007/s00330-015-4136-y. Epub 2015 Dec 3. Identification of Imaging Predictors Discriminating Different Primary Liver Tumours in Patients with Chronic Liver Disease on Gadoxetic Acid-enhanced MRI: a Classification Tree Analysis Park HJ11, Jang KM2, Kang TW3, Song KD3, Kim SH3, Kim YK3, Cha DI3, Kim J4, Goo J4.
    View PubMed
  • Clin Radiol. 2016 Apr;71(4):402.e9-402.e15. doi: 10.1016/j.crad.2016.01.004. Epub 2016 Feb 10. Tumefactive gallbladder sludge: the MRI findings Seong M11, Kang TW2, Kim M1, Kim SS1, Jang KM1, Kim YK1, Kim SH1.
    View PubMed
  • Eur J Radiol. 2016 Mar;85(3):680-7. doi: 10.1016/j.ejrad.2015.12.029. Epub 2016 Jan 4. Pancreatic neuroendocrine tumour: Correlation of apparent diffusion coefficient or WHO classification with recurrence-free survival Kim M11, Kang TW2, Kim YK1, Kim SH1, Kwon W3, Ha SY4, Ji SA5.
    View PubMed
  • Medicine (Baltimore). 2016 Feb;95(7):e2718. doi: 10.1097/MD.0000000000002718. Predicting Hepatic Steatosis in Living Liver Donors via Noninvasive Methods Kim JM11, Ha SY, Joh JW, Sinn DH, Jeong WK, Choi GS, Gwak GY, Kwon CH, Kim YK, Paik YH, Lee JH, Lee WJ, Lee SK, Park CK.
    View PubMed
  • Korean J Radiol. 2015 Sep-Oct;16(5):1038-46. doi: 10.3348/kjr.2015.16.5.1038. Epub 2015 Aug 21. T2-Weighted Liver MRI Using the MultiVane Technique at 3T: Comparison with Conventional T2-Weighted MRI Kang KA11, Kim YK2, Kim E3, Jeong WK2, Choi D2, Lee WJ2, Jung SH4, Baek SY4.
    View PubMed
  • Eur J Radiol. 2015 Aug;84(8):1473-9. doi: 10.1016/j.ejrad.2015.05.012. Epub 2015 May 18. Missed pancreatic ductal adenocarcinoma: Assessment of early imaging findings on prediagnostic magnetic resonance imaging Jang KM11, Kim SH2, Kim YK1, Song KD1, Lee SJ1, Choi D1.
    View PubMed
  • Radiology.?2015 Oct;277(1):309. doi: 10.1148/radiol.2015154031. Nonhypervascular Hypointense Nodules at Gadoxetic Acid-enhanced MR Imaging in Chronic Liver Disease: Diffusion-weighted Imaging for Characterization Hwang J1,?Kim YK,?Jeong WK,?Choi D,?Rhim H,?Lee WJ.
    View PubMed
  • Eur Radiol. 2015 Jun;25(6):1551-60. doi: 10.1007/s00330-014-3548-4. Epub 2014 Dec 14. Pancreatic duct "Icicle sign" on MRI for distinguishing autoimmune pancreatitis from pancreatic ductal adenocarcinoma in the proximal pancreas Kim HJ11, Kim YK, Jeong WK, Lee WJ, Choi D.
    View PubMed
  • Eur J Radiol. 2015 Jun;84(6):1036-43. doi: 10.1016/j.ejrad.2015.03.002. Epub 2015 Mar 14. Prediction of microvascular invasion of hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging: Impact of intra-tumoral fat detected on chemical-shift images Min JH11, Kim YK2, Lim S3, Jeong WK1, Choi D1, Lee WJ1.
    View PubMed
  • Acta Radiol. 2015 May;56(5):526-35. doi: 10.1177/0284185114534652. Epub 2014 May 16. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease Jang KM11, Kim SH2, Kim YK1, Choi D1.
    View PubMed
  • Korean J Radiol. 2015 May-Jun;16(3):465-522. doi: 10.3348/kjr.2015.16.3.465. Epub 2015 May 13. 2014 Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guideline for the Management of Hepatocellular Carcinoma Korean Liver Cancer Study Group (KLCSG); National Cancer Center1, Korea (NCC).
    View PubMed
  • Clin Radiol. 2015 Apr;70(4):408-15. doi: 10.1016/j.crad.2014.12.007. Epub 2015 Jan 2. Diffusion-weighted imaging of the liver at 3 T using section-selection gradient reversal: emphasis on chemical shift artefacts and lesion conspicuity Lee JS11, Kim YK2, Jeong WK1, Choi D1, Lee WJ1.
    View PubMed
  • Abdom Imaging.?2015 Apr;40(4):835-42. doi: 10.1007/s00261-014-0249-z. Frequency, CT findings, and fate of multiple infarcted regenerative nodules in liver cirrhosis after variceal bleeding or septic shock Lee S11,?Choi D,?Jeong WK,?Kim YK,?Lim JH,?Choi MS,?Park CK.
    View PubMed
  • Clin Radiol. 2015 Feb;70(2):153-60. doi: 10.1016/j.crad.2014.10.010. Epub 2014 Nov 22. Differentiation of solid-type serous cystic neoplasm from neuroendocrine tumour in the pancreas: value of abdominal MRI with diffusion-weighted imaging in comparison with MDCT Jang KM11, Kim SH2, Song KD1, Kim YK1, Lee SJ1, Choi D1.
    View PubMed
  • Magn Reson Imaging. 2014 Dec;32(10):1214-22. doi: 10.1016/j.mri.2014.08.029. Epub 2014 Sep 3. Is gadoxetic acid-enhanced MRI limited in tumor characterization for patients with chronic liver disease Kwon S11, Kim YK2, Park HJ3, Jeong WK1, Lee WJ1, Choi D1.
    View PubMed
  • Liver Transpl. 2014 Dec;20(12):1436-46. doi: 10.1002/lt.23974. Epub 2014 Nov 7. Pretransplant Diagnosis of Hepatocellular Carcinoma by Gadoxetic Acid-Enhanced and Diffusion-Weighted Magnetic Resonance Imaging Hwang J11, Kim YK, Kim JM, Lee WJ, Choi D, Hong SS.
    View PubMed
  • Radiology. 2014 Nov;273(2):433-43. doi: 10.1148/radiol.14132563. Epub 2014 Jul 4. Preoperative Detection of Small Pancreatic Adenocarcinoma: Value of Adding Diffusion-weighted Imaging to Conventional MR Imaging for Improving Confidence Level Park MJ11, Kim YK, Choi SY, Rhim H, Lee WJ, Choi D.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):814-21. doi: 10.1016/j.ijrobp.2014.03.020. The Role of Diffusion-Weighted Magnetic Resonance Imaging in the Treatment Response Evaluation of Hepatocellular Carcinoma Patients Treated With Radiation Therapy Yu JI11, Park HC2, Lim DH1, Choi Y1, Jung SH1, Paik SW3, Kim SH4, Jeong WK4, Kim YK4.
    View PubMed
  • Magn Reson Imaging. 2014 Jul;32(6):610-8. doi: 10.1016/j.mri.2013.12.021. Epub 2014 Jan 13. Noncontrast MRI with diffusion-weighted imaging as the sole imaging modality for detecting liver malignancy in patients with high risk for hepatocellular carcinoma Kim YK11, Kim YK2, Park HJ1, Park MJ1, Lee WJ1, Choi D1.
    View PubMed
  • J Magn Reson Imaging. 2014 May;39(5):1238-45. doi: 10.1002/jmri.24265. Epub 2013 Oct 17. Infiltrative hepatocellular carcinoma on gadoxetic acid-enhanced and diffusion-weighted MRI at 3.0T Lim S11, Kim YK, Park HJ, Lee WJ, Choi D, Park MJ.
    View PubMed
  • Clin Radiol. 2014 Apr;69(4):416-23. doi: 10.1016/j.crad.2013.11.015. Epub 2014 Jan 20. Pancreatic ductal adenocarcinoma: Prevalence and diagnostic value of dark choledochal ring sign on T2-weighted MRI Cha DI11, Kim YK2, Choi SY1, Lim SH1, Choi D1, Lee WJ1.
    View PubMed
  • J Magn Reson Imaging. 2014 Apr;39(4):842-52. doi: 10.1002/jmri.24237. Epub 2013 Sep 30. Assessing Patients With hepatocellular Carcinoma Meeting the Milan Criteria: Is Liver 3 Tesla MR With Gadoxetic Acid Necessary in Addition to Liver CT Cha DI11, Lee MW, Kim YK, Kim SH, Park HJ, Rhim H, Lim HK.
    View PubMed
  • Radiology. 2014 Mar;270(3):768-76. doi: 10.1148/radiol.13130009. Epub 2013 Oct 30. Hilar Cholangiocarcinoma: Value of Adding DW Imaging to Gadoxetic Acid-enhanced MR Imaging with MR Cholangiopancreatography for Preoperative Evaluation Park MJ11, Kim YK, Lim S, Rhim H, Lee WJ.
    View PubMed
  • Abdom Imaging. 2014 Feb;39(1):142-52. doi: 10.1007/s00261-013-0044-2. Feasibility of blood oxygenation level-dependent MRI at 3T in the characterization of hepatic tumors Park HJ11, Kim YK, Min JH, Lee WJ, Choi D, Rhim H.
    View PubMed
  • Br J Radiol. 2014 Jan;87(1033):20130608. doi: 10.1259/bjr.20130608. Epub 2013 Nov 28. Gadoxetic acid-enhanced MRI for T-staging of gallbladder carcinoma: emphasis on liver invasion Hwang J11, Kim YK, Choi D, Rhim H, Lee WJ, Hong SS, Kim HJ, Chang YW.
    View PubMed
  • J Magn Reson Imaging. 2014 Jan;39(1):31-41. doi: 10.1002/jmri.24122. Epub 2013 Sep 24 Diagnosis of Focal Liver Lesions With Gadoxetic Acid-Enhanced MRI: Is a Shortened Delay Time Possible by Adding Diffusion-weighted Imaging Kim MY11, Kim YK, Park HJ, Park MJ, Lee WJ, Choi D.
    View PubMed
  • J Comput Assist Tomogr. 2013 Nov-Dec;37(6):872-81. doi: 10.1097/RCT.0b013e31829d44c1. Scirrhous Hepatocellular Carcinoma on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging and Diffusion-Weighted Imaging: Emphasis on the Differentiation of Intrahepatic Cholangiocarcinoma Park MJ11, Kim YK, Park HJ, Hwang J, Lee WJ.
    View PubMed
  • J Comput Assist Tomogr. 2013 Nov-Dec;37(6):856-61. doi: 10.1097/RCT.0b013e31829002ca. Unenhanced Magnetic Resonance Portography Using Repetitive Arterial or Vein Labeling Method at 3.0-T Hwang J11, Kim YK, Lee WJ, Choi D, Park MJ, Park HJ, Hong SS, Lee MH.
    View PubMed
  • Abdom Imaging.?2013 Oct;38(5):1115-9. doi: 10.1007/s00261-013-9993-8. Intraductal growing acinar cell carcinoma of the pancreas Kim HJ11,?Kim YK,?Jang KT,?Lim JH.
    View PubMed
  • Abdom Imaging. 2013 Oct;38(5):1082-90. doi: 10.1007/s00261-013-9989-4. Intraductal papillary neoplasm of the bile ducts: description of MRI and added value of diffusion-weighted MRI Yoon HJ11, Kim YK, Jang KT, Lee KT, Lee JK, Choi DW, Lim JH.
    View PubMed
  • J Magn Reson Imaging. 2013 Aug;38(2):401-10. doi: 10.1002/jmri.23983. Epub 2013 Jan 4. Gadoxetic acid-enhanced fat suppressed three-dimensional T1-weighted MRI using a multiecho dixon technique at 3 tesla: Emphasis on image quality and hepatocellular carcinoma detection Lee MH11, Kim YK, Park MJ, Hwang J, Kim SH, Lee WJ, Choi D.
    View PubMed
  • Abdom Imaging. 2013 Aug;38(4):793-801. doi: 10.1007/s00261-012-9943-x. Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma Park HJ11, Kim YK, Park MJ, Lee WJ.
    View PubMed
  • Radiology. 2013 Apr;267(1):317-8. doi: 10.1148/radiol.13122186. Hypovascular Hypointense Nodules on Hepatocyte Phase Gadoxetic Acid-enhanced MR Images: Too Early or Too Progressed to Determine Hypervascularity Response 1,Motosugi U.
    View PubMed
  • Acta Radiol. 2013 Mar 1;54(2):127-36. doi: 10.1258/ar.2012.120262. Epub 2012 Nov 12. Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis Park MJ11, Kim YK, Lee MH, Lee JH.
    View PubMed
  • Differentiating Combined Hepatocellular and Cholangioc cinoma from Mass-Forming Intrahepatic Chol gioc cinoma Using Gadoxetic Acid-Enh ced MRI
  • Radiology. 2012 Oct;265(1):104-14. Epub 2012 Aug 13. Hypovascular Hypointense Nodules on Hepatobiliary Phase Gadoxetic Acid-enhanced MR Images in Patients with Cirrhosis: Potential of DW Imaging in Predicting Progression to Hypervascular HCC Kim YK11, Lee WJ, Park MJ, Kim SH, Rhim H, Choi D.
    View PubMed
  • Acta Radiol. 2012 Oct 1;53(8):830-8. doi: 10.1258/ar.2012.120099. Epub 2012 Jul 30. Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis Kim AY11, Kim YK, Lee MW, Park MJ, Hwang J, Lee MH, Lee JW.
    View PubMed
  • J Comput Assist Tomogr. 2012 Sep-Oct;36(5):546-53. Liver MRI at 3.0 Tesla: Comparison of Image Quality and Lesion Detectability Between Single-Source Conventional and Dual-Source Parallel Radiofrequency Transmissions Hwang J11, Kim YK, Park MJ, Lee MH, Kim SH, Lee WJ, Choi D.
    View PubMed
  • Radiology. 2012 Sep;264(3):761-70. doi: 10.1148/radiol.12112517. Epub 2012 Jul 27. Small Hepatocellular Carcinomas: Improved Sensitivity by Combining Gadoxetic Acid-enhanced and Diffusion-weighted MR Imaging Patterns Park MJ11, Kim YK, Lee MW, Lee WJ, Kim YS, Kim SH, Choi D, Rhim H.
    View PubMed
  • Clin Radiol. 2012 Aug;67(8):766-73. doi: 10.1016/j.crad.2012.01.004. Epub 2012 Mar 15. Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using gadoxetic acid-enhanced MRI Chong YS11, Kim YK, Lee MW, Kim SH, Lee WJ, Rhim HC, Lee SJ.
    View PubMed
  • Acta Radiol. 2012 Jun 1;53(5):485-93. doi: 10.1258/ar.2012.110437. Epub 2012 Apr 25. Detection and characterization of small focal hepatic lesions (<= 2.5 cm in diameter): a comparison of diffusion-weighted images before and after administration of gadoxetic acid disodium at 3.0T Song KD11, Kim YK, Lee WJ, Lee MW, Park MJ, Hwang J, Lee MH.
    View PubMed
  • Br J Radiol. 2012 May;85(1013):539-47. doi: 10.1259/bjr/25139667. Diagnostic efficacy of gadoxetic acid-enhanced MRI for the detection and characterisation of liver metastases: comparison with multidetector-row CT Kim YK11, Park G, Kim CS, Yu HC, Han YM.
    View PubMed
  • Invest Radiol. 2012 Mar;47(3):159-66. doi: 10.1097/RLI.0b013e31823a1495. Diagnostic Accuracy and Sensitivity of Diffusion-Weighted and of Gadoxetic Acid-Enhanced 3-T MR Imaging Alone or in Combination in the Detection of Small Liver Metastasis (<= 1.5 cm in Diameter) Kim YK11, Lee MW, Lee WJ, Kim SH, Rhim H, Lim JH, Choi D, Kim YS, Jang KM, Lee SJ, Lim HK.
    View PubMed
  • AJR Am J Roentgenol. 2011 Nov;197(5):1111-20. doi: 10.2214/AJR.10.6363. Cyst-Forming Intraductal Papillary Neoplasm of the Bile Ducts: Description of Imaging and Pathologic Aspects Lim JH11, Zen Y, Jang KT, Kim YK, Nakanuma Y.
    View PubMed
  • Clin Radiol. 2011 Jun;66(6):489-96. doi: 10.1016/j.crad.2010.09.007. Epub 2011 Mar 1. Detection of liver malignancy with gadoxetic acid-enhanced MRI: Is addition of diffusion-weighted MRI beneficial (vol 66, pg 489, 2011) Kim YK11, Kim CS, Han YM, Lee YH.
    View PubMed
  • Invest Radiol. 2011 Jun;46(6):383-9. doi: 10.1097/RLI.0b013e318217b8fb. Detection of Small Hepatocellular Carcinoma: Intraindividual Comparison of Gadoxetic Acid-Enhanced MRI at 3.0 and 1.5 T (vol 46, pg 383, 2011) Kim YK11, Kim CS, Han YM, Yu HC, Choi D.
    View PubMed
  • Abdom Imaging. 2011 Aug;36(4):425-32. doi: 10.1007/s00261-011-9752-7. Differentiating focal eosinophilic liver disease from hepatic metastases using unenhanced and gadoxetic acid-enhanced MRI Kim YK11, Lee YH, Kim CS, Lee MW.
    View PubMed
  • Invest Radiol. 2011 Jun;46(6):383-9. doi: 10.1097/RLI.0b013e318217b8fb. Detection of Small Hepatocellular Carcinoma Intraindividual Comparison of Gadoxetic Acid-Enhanced MRI at 3.0 and 1.5 T Kim YK11, Kim CS, Han YM, Yu HC, Choi D.
    View PubMed
  • Br J Radiol. 2010 Dec;83(996):1010-6. doi: 10.1259/bjr/66686028. Epub 2010 Aug 3. Diagnostic efficacy of gadoxetic acid-enhanced MRI in the detection of hepatocellular carcinomas: comparison with gadopentetate dimeglumine Park G11, Kim YK, Kim CS, Yu HC, Hwang SB.
    View PubMed
  • J Atheroscler Thromb. 2010 Dec 26;17(12):1218-25. Epub 2010 Aug 27. Serum Folate and Low-Density Lipoprotein Particle Size Kim DS11, Kim YK, Park HK, Cho YI, Jeong SK.
    View PubMed
  • Invest Radiol. 2010 Nov;45(11):740-6. doi: 10.1097/RLI.0b013e3181e943a7. Detection of Small Hepatocellular Carcinoma Can Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Replace Combining Gadopentetate Dimeglumine-Enhanced and Superparamagnetic Iron Oxide-Enhanced Magnetic Resonance Imaging Kim YK11, Kim CS, Han YM, Park G.
    View PubMed

해당하는 결과가 없습니다.